174 related articles for article (PubMed ID: 23015149)
21. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
22. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
24. Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Han I; Lee MR; Nam KW; Oh JH; Moon KC; Kim HS
Clin Orthop Relat Res; 2008 Sep; 466(9):2107-13. PubMed ID: 18563508
[TBL] [Abstract][Full Text] [Related]
25. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.
Oda Y; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Yokoyama R; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 May; 19(5):738-45. PubMed ID: 16528367
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
28. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
29. [Survival analysis of 104 cases of osteosarcoma with lung metastases].
Ren J; Xu YF; Kuang TH; Chen J; Liu YX
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):263-268. PubMed ID: 28550665
[No Abstract] [Full Text] [Related]
30. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.
Hu F; Shang XF; Wang W; Jiang W; Fang C; Tan D; Zhou HC
Int J Exp Pathol; 2016 Feb; 97(1):86-92. PubMed ID: 27028305
[TBL] [Abstract][Full Text] [Related]
31. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
32. Green fluorescent protein (GFP)-expressing tumor model derived from a spontaneous osteosarcoma in a vascular endothelial growth factor (VEGF)-GFP transgenic mouse.
Huang P; McKee TD; Jain RK; Fukumura D
Comp Med; 2005 Jun; 55(3):236-43. PubMed ID: 16089171
[TBL] [Abstract][Full Text] [Related]
33. [The correlation between the level of serum VEGF and bFGF with metastasis and prognosis of osteosarcoma].
Chen GL; Lin HB; Wu XW; Li RY; Chen XH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Dec; 27(12):1343-5. PubMed ID: 22368795
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
Zhao H; Wu Y; Chen Y; Liu H
Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
[TBL] [Abstract][Full Text] [Related]
38. The relation of tumour necrosis and survival in patients with osteosarcoma.
Li X; Ashana AO; Moretti VM; Lackman RD
Int Orthop; 2011 Dec; 35(12):1847-53. PubMed ID: 21359502
[TBL] [Abstract][Full Text] [Related]
39. Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.
Chen Z; Chen QX; Hou ZY; Hu J; Cao YG
Asian Pac J Cancer Prev; 2012; 13(9):4823-6. PubMed ID: 23167426
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
